ZOM
Zomedica Corp
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
zomedica (nyse american:zom) (tsx-v:zom) is a veterinary diagnostic and pharmaceutical and company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. zomedica’s product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. with a team that includes clinical veterinary professionals, it is zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care.
Market Cap: 130 Million
Primary Exchange: NYSE MKT LLC
Website: zomedica.com
Shares Outstanding: 980 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.2535757966155274
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1008 trading days
From: 2018-06-22 To: 2024-03-07
Lowest Point:
Zomedica closes second tranche of Preferred Shares
via: SeekingAlpha at 2019-06-10 04:38:09:000
Zomedica Pharmaceuticals (NYSEMKT: ZOM ) has completed the closing of its second tranche of Series 1 Preferred Shares with the issuance of 7 Series 1 Preferred Shares under a private placement at $1M per Series for a total purchase price of $7M. More news on: Zomedica Pharmaceuticals Cor… read more...
Zomedica closes second tranche of Preferred Shares
via: SeekingAlpha at 2019-06-10 04:38:09:000
Zomedica Pharmaceuticals (NYSEMKT: ZOM ) has completed the closing of its second tranche of Series 1 Preferred Shares with the issuance of 7 Series 1 Preferred Shares under a private placement at $1M per Series for a total purchase price of $7M. More news on: Zomedica Pharmaceuticals Cor… read more...
Zomedica closes second tranche of Preferred Shares
via: SeekingAlpha at 2019-06-10 04:38:09:000
Zomedica Pharmaceuticals (NYSEMKT: ZOM ) has completed the closing of its second tranche of Series 1 Preferred Shares with the issuance of 7 Series 1 Preferred Shares under a private placement at $1M per Series for a total purchase price of $7M. More news on: Zomedica Pharmaceuticals Cor… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|